Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

2.75
-0.0400-1.43%
Post-market: 2.51-0.2400-8.73%16:41 EDT
Volume:6.19K
Turnover:16.93K
Market Cap:4.09M
PE:-0.66
High:2.81
Open:2.79
Low:2.67
Close:2.79
Loading ...

Jefferies Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
6 hours ago

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported And Analysts Have Been Cutting Their Estimates

Simply Wall St.
·
16 Mar

Evoke Pharma’s Earnings Call Highlights Revenue Growth and Strategic Partnerships

TIPRANKS
·
15 Mar

Evoke Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Mar

Q4 2024 Evoke Pharma Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Mar

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans

GuruFocus.com
·
14 Mar

Evoke Pharma Reports Strong Revenue Growth in 2024

TIPRANKS
·
14 Mar

Evoke Pharma Q4 Sales $3.31M Beat $3.08M Estimate

Benzinga
·
14 Mar

Evoke Pharma Inc: Projects Net Revenue in 2025 of Approximately $16 Mln

THOMSON REUTERS
·
14 Mar

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
14 Mar

Evoke Pharma Inc expected to post a loss of 63 cents a share - Earnings Preview

Reuters
·
12 Mar

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025

GlobeNewswire
·
06 Mar

Evoke Pharma Appoints Greg Pyszcymuka as Director

TIPRANKS
·
24 Feb

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors

THOMSON REUTERS
·
24 Feb

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors

GlobeNewswire
·
24 Feb

Berenberg Bank Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
21 Jan